US › Healthcare

Femasys Inc (FEMY)

US · Healthcare · Medical Instruments & Supplies

$1.65-4.90%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$331,827

Revenue YoY

-18.9%

Net profit

$-4.5M

EPS

$-1.33

EPS estimate

$-1.40

Net margin

-1,346.8%

EPS came in at -1.33 against a street estimate of -1.40 — a beat of 5.0%.

Key statistics

Market cap

$14.5M

Forward P/E

0.0

P/B

5.28

Book value

$1.33

EPS (TTM)

$-3.23

52-week high

$22.20

52-week low

$1.46

50-day MA

$2.52

200-day MA

$6.77

Beta

-2.15

Analyst view

Analysts rate Femasys Inc a buy (3 buy, 0 hold, 0 sell out of 3) with an average price target of $14.33.

Shareholding

Insiders

3.92%

Institutions

52.85%

Largest institutional holders

Fund	Stake
Dauntless Investment Group, LLC	22.30%
Vanguard Capital Management, LLC	0.74%
Jane Street Group LLC	0.63%
Geode Capital Management, LLC	0.37%
UBS Group AG	0.22%
Citadel Advisors Llc	0.20%
Vanguard Fiduciary Trust Co	0.15%
Advisor Group Holdings, Inc.	0.03%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Femasys Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.